内皮系统在心脏移植排斥反应中的研究进展

黄霞; 任伟; 阮永乐; 胡锐; 石烽; 吴智勇

doi:10.14188/j.1671-8852.2024.0011

您当前的位置：

首页 >

文章列表页 >

内皮系统在心脏移植排斥反应中的研究进展

综述与Meta分析 | 更新时间：2026-11-05

- 内皮系统在心脏移植排斥反应中的研究进展
- Research advances of endothelium system on rejection in the heart transplantation
- 武汉大学学报（医学版） 2025年46卷第3期页码：403-406
- 作者机构：
  
  1.武汉大学人民医院心血管外科湖北武汉 430060
  2.心血管病湖北省重点实验室湖北武汉 430060
  3.武汉大学心血管病研究所湖北武汉 430060
- 作者简介：
  
  黄霞，女，1996—，医学硕士生，主要从事心脏移植的基础与临床研究，E‑mail：kasumi0903@foxmail.com
  吴智勇，男，1977—，医学博士，主任医师，硕士生导师，主要从事主动脉夹层肺损伤、心脏移植的心肌保护等研究，E‑mail：wzy2008@whu.edu.cn
- 基金信息：
  
  国家自然科学基金资助项目(82300539)
- DOI：10.14188/j.1671-8852.2024.0011
  中图分类号： R392.4
- 纸质出版：2025-03-25
- 稿件说明：
移动端阅览
黄霞,任伟,阮永乐等.内皮系统在心脏移植排斥反应中的研究进展[J].武汉大学学报（医学版）,2025,46(03):403-406.

HUANG Xia,REN Wei,RUAN Yongle,et al.Research advances of endothelium system on rejection in the heart transplantation[J].Medical Journal of Wuhan University,2025,46(03):403-406.
黄霞,任伟,阮永乐等.内皮系统在心脏移植排斥反应中的研究进展[J].武汉大学学报（医学版）,2025,46(03):403-406. DOI： 10.14188/j.1671-8852.2024.0011.

HUANG Xia,REN Wei,RUAN Yongle,et al.Research advances of endothelium system on rejection in the heart transplantation[J].Medical Journal of Wuhan University,2025,46(03):403-406. DOI： 10.14188/j.1671-8852.2024.0011.

摘要

心脏移植手术是治疗终末期心力衰竭的最佳治疗方式，而影响心脏移植术后患者生存率的重要原因为排斥反应的发生。移植物内皮细胞表面所表达的抗原与受体内免疫系统相互作用所产生的体液免疫、细胞免疫反应在排斥反应中起到核心作用。内皮细胞表达抗原种类及数量的检测可作为预测术后治疗效果的重要指标，以移植物内皮系统为靶点的不同治疗方式的研究具有广阔的前景。

Abstract

Nowadays

heart transplantation is the best way to treat end‑stage heart failure

and the major cause of graft failure is rejection. The humoral and cellular immunity caused by the interaction between antigens presented on the endothelial cells of the graft and the immune system are the core mechanisms of rejection. Antigens expressed on the endothelial cells can be regarded as an important indicator predicting the outcome of the transplantation

and research on treatments targeting the graft endothelium holds great promise.

关键词

Keywords

references

KIM I C , YOUN J C , KOBASHIGAWA J A . The past, present and future of heart transplantation [J ] . Korean Circ J , 2018 , 48 ( 7 ): 565 ‑ 590 .

FERREIRA A , FERREIRA V , ANTUNES M M , et al . Dilated cardiomyopathy: A comprehensive approach to diagnosis and risk stratification [J ] . Biomedicines , 2023 , 11 ( 3 ): 834 .

LIBURD S T , SHI A A , POBER J S , et al . Wanted: An endothelial cell targeting atlas for nanotherapeutic delivery in allograft organs [J ] . Am J Transplant , 2022 , 22 ( 7 ): 1754 ‑ 1759 .

WANG X , ZHANG F , JIANG Y , et al . Highly individual‑ and tissue‑specific expression of glycoprotein group A and B blood antigens in the human kidney and liver [J ] . BMC Immunol , 2021 , 22 ( 1 ): 66 .

CHAUHAN D , ORLANDI V , RAJAB T K , et al . Postoperative outcomes in infants undergoing ABO‑incompatible heart transplantation in the United States [J ] . Ann Thorac Surg , 2022 , 114 ( 5 ): 1746 ‑ 1752 .

LEHLE K , KROHER J , KOLAT P , et al . Existence of circulating anti‑endothelial cell antibodies after heart transplantation is associated with post‑transplant acute allograft rejection [J ] . Heart Vessels , 2016 , 31 ( 5 ): 752 ‑ 757 .

WANG S , ZHANG C , WANG J , et al . Endothelial cells in antibody‑mediated rejection of kidney transplantation: pathogenesis mechanisms and therapeutic implications [J ] . J Immunol Res , 2017 , 2017 : 8746303 .

NUNODA S . Impact of pretransplant antibodies on outcomes after heart transplantation [J ] . Curr Opin Organ Transplant , 2019 , 24 ( 3 ): 220 ‑ 226 .

MUNTJEWERFF E M , MEESTERS L D , VAN DEN BOGAART G , et al . Reverse signaling by MHC‑I molecules in immune and non‑immune cell types [J ] . Front Immunol , 2020 , 11 : 605958 .

BOUQUEGNEAU A , LOHEAC C , AUBERT O , et al . Complement‑activating donor‑specific anti‑HLA antibodies and solid organ transplant survival: A systematic review and meta‑analysis [J ] . PLoS Med , 2018 , 15 ( 5 ): e1002572 .

MANGIOLA M , MARRARI M , FEINGOLD B , et al . Significance of anti‑HLA antibodies on adult and pediatric heart allograft outcomes [J ] . Front Immunol , 2017 , 8 : 4 .

FRANDSEN E L , ALBERS E L . Management of the sensitized pediatric heart transplant patient [J ] . Transl Pediatr , 2019 , 8 ( 4 ): 302 ‑ 313 .

TOLDO S , QUADER M , SALLOUM F N , et al . Targeting the innate immune response to improve cardiac graft recovery after heart transplantation: Implications for the donation after cardiac death [J ] . Int J Mol Sci , 2016 , 17 ( 6 ): E958 .

BAHRAM S , BRESNAHAN M , GERAGHTY D E , et al . A second lineage of mammalian major histocompatibility complex class I genes [J ] . Proc Natl Acad Sci U S A , 1994 , 91 ( 14 ): 6259 ‑ 6263 .

JEON J H , BAEK I C , HONG C H , et al . Establishment of HLA class I and MICA /B null HEK‑293T panel expressing single MICA alleles to detect anti‑ MICA antibodies [J ] . Sci Rep , 2021 , 11 : 15716 .

BHARAT A , MOHANAKUMAR T . Immune responses to tissue‑restricted nonmajor histocompatibility complex antigens in allograft rejection [J ] . J Immunol Res , 2017 , 2017 : 6312514 .

SEE S B , MANTELL B S , CLERKIN K J , et al . Profiling non‑HLA antibody responses in antibody‑mediated rejection following heart transplantation [J ] . Am J Transplant , 2020 , 20 ( 9 ): 2571 ‑ 2580 .

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

原位心脏移植术治疗成人终末期心脏病24例总结

家兔脑死亡影响心肌细胞凋亡的机制

核因子-κB抑制剂熊果酸延长小鼠心脏移植物存活时间

小鼠腹部心脏移植模型的建立及技术改进

异丙酚调控Nrf2/HO‑1信号通路对哮喘小鼠气道炎症的影响